$Tempest Therapeutics (TPST.US)$ Maybe Up 10~30% tomorrow

$Tempest Therapeutics (TPST.US)$ looking juicy

$Revance Therapeutics (RVNC.US)$ when the deal is over this should start with 6,60 easy

$Revance Therapeutics (RVNC.US)$ The deal is going forward . It is free for $0.7 per share. Bought more

$Tonix Pharmaceuticals (TNXP.US)$ As TNXP investors, they ask about the vote for RS and increase public shares by management. My answer is "NO"
Hopefully, TNXP  share holders doing the same thing.
The approval of a proposal to authorize the Company’s Board of Directors (the “Board”), in its discretion at any time within one year after shareholder approval is obtained, to effect a reverse stock split of then-outstanding shares of the Company’s common stock, at a ratio of not less than one-for-two...

$Tonix Pharmaceuticals (TNXP.US)$ It finally submitted its NDA after many years of effort and huge investment losses. Completely Agree, it is a deep blood pool if you look at its chart. The early investors lost most of the money. Good news is that $Tonix Pharmaceuticals (TNXP.US)$ is survived and has its NDA. TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast Track designation by FDA. It is easy to use under tongue and has quick effects. It also improve...

$Tonix Pharmaceuticals (TNXP.US)$ they can not keep this down forever

Happy Friday traders. The market climbed across the board again, with the S&P 500 within 50 points of an all-time high. My name is Kevin Travers; here are stories moving on the U.S. stock market today.
Adobe $Adobe (ADBE.US)$ shares fell 8% Friday after the firm's Thursday Q4 revenue outlook missed estimates. It was the lowest decliner on the S&P 500. The firm said it expected Q4 revenue to be between $5.50 billion and $5.55 billion. Analys...